endolinx Medical News

Endocrinology

Become a Member Today!

Email
Password
Remember me
Forgot your Password?
Invite Code?

Home
General Endocrinology

Messages

Conferences

Jobs

Newsletters

My Library

Topics in
Endocrinology

Adrenal Glands

Atherosclerosis/Lipids

Basic Science/Genetics

Bone Metabolism

Diabetes

Diagnostics

Economics of Medicine

Endocrine Oncology

Fetal Development

Hypertension

Metabolism and Growth

Neuroendocrinology

Obesity

Pediatric Endocrinology

Pharmacology/kinetics

Popular Press

Primary Care

Reproductive
Endocrinology

Thyroid/Parathyroid

Help

Resource Center

RSS News Feeds

Send Newsletter
to a Friend

Sponsor

FDA Update: Thyrotropin Approved For Thyroid Cancer Ablation
Tracy Hampton, PhD, MDLinx Oncology

See all

Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website

Lipidomics-Based Safety Biomarkers for Lipid-Lowering Treatments
Angiology, 07/18/08

Email This Article

Save in My Library

Free Abstract

Laaksonen R et al. - Results suggest that the plasma lipidomic profile may serve as a highly sensitive biomarker of statin-induced metabolic alterations in muscle and may thus allow us to identify patients who should be treated with a lower dose to prevent a possible toxicity.

Sponsor

--- ATHEROSCLEROSIS/LIPIDS TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email

A Practical "ABCDE" Approach to the Metabolic Syndrome
Mayo Clinic Proceedings, 08/05/08

Pharmacologic Management of Isolated Low High-Density Lipoprotein Syndrome
American Journal of Therapeutics, 07/24/08

Computed tomography imaging, coronary calcium and atherosclerosis
Expert Review of Cardiovascular Therapy , 09/19/08

...All of Atherosclerosis/Lipids